Downregulation of caveolin by chronic beta-adrenergic receptor stimulation in mice. 1997

N Oka, and K Asai, and R K Kudej, and J G Edwards, and Y Toya, and C Schwencke, and D E Vatner, and S F Vatner, and Y Ishikawa
Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA.

Caveolae, flask-shaped invaginations of cell membranes, are believed to play pivotal roles in transmembrane transportation of molecules and cellular signaling. Caveolin, a structural component of caveolae, interacts directly with G proteins and regulates their function. We investigated the effect of chronic beta-adrenergic receptor stimulation on the expression of caveolin subtypes in mouse hearts by immunoblotting and Northern blotting. Caveolin-1 and -3 were abundantly expressed in the heart and skeletal muscles, but not in the brain. Continuous (-)-isoproterenol, but not (+)-isoproterenol, infusion via osmotic minipump (30 micrograms.g-1.day-1) for 13 days significantly downregulated both caveolin subtypes in the heart. The expression of caveolin-1 was reduced by 48 +/- 6.1% and that of caveolin-3 by 28 +/- 4.0% (P < 0.01, n = 8 for each). The subcellular distribution of caveolin subtypes in ventricular myocardium was not altered as determined by sucrose gradient fractionation. In contrast, the expression of both caveolin subtypes in skeletal muscles was not significantly changed. Our data suggest that the expression of caveolin subtypes is regulated by beta-adrenergic receptor stimulation in the heart.

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D007545 Isoproterenol Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant. Isoprenaline,Isopropylarterenol,4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol,Euspiran,Isadrin,Isadrine,Isopropyl Noradrenaline,Isopropylnoradrenaline,Isopropylnorepinephrine,Isoproterenol Hydrochloride,Isoproterenol Sulfate,Isuprel,Izadrin,Norisodrine,Novodrin,Hydrochloride, Isoproterenol,Noradrenaline, Isopropyl,Sulfate, Isoproterenol
D008297 Male Males
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D011943 Receptors, Adrenergic, beta One of two major pharmacologically defined classes of adrenergic receptors. The beta adrenergic receptors play an important role in regulating CARDIAC MUSCLE contraction, SMOOTH MUSCLE relaxation, and GLYCOGENOLYSIS. Adrenergic beta-Receptor,Adrenergic beta-Receptors,Receptors, beta-Adrenergic,beta Adrenergic Receptor,beta-Adrenergic Receptor,beta-Adrenergic Receptors,Receptor, Adrenergic, beta,Adrenergic Receptor, beta,Adrenergic beta Receptor,Adrenergic beta Receptors,Receptor, beta Adrenergic,Receptor, beta-Adrenergic,Receptors, beta Adrenergic,beta Adrenergic Receptors,beta-Receptor, Adrenergic,beta-Receptors, Adrenergic
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D005260 Female Females
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D006325 Heart Atria The chambers of the heart, to which the BLOOD returns from the circulation. Heart Atrium,Left Atrium,Right Atrium,Atria, Heart,Atrium, Heart,Atrium, Left,Atrium, Right

Related Publications

N Oka, and K Asai, and R K Kudej, and J G Edwards, and Y Toya, and C Schwencke, and D E Vatner, and S F Vatner, and Y Ishikawa
October 1997, Journal of molecular and cellular cardiology,
N Oka, and K Asai, and R K Kudej, and J G Edwards, and Y Toya, and C Schwencke, and D E Vatner, and S F Vatner, and Y Ishikawa
November 2006, Journal of cardiovascular pharmacology,
N Oka, and K Asai, and R K Kudej, and J G Edwards, and Y Toya, and C Schwencke, and D E Vatner, and S F Vatner, and Y Ishikawa
May 1998, Cardiovascular research,
N Oka, and K Asai, and R K Kudej, and J G Edwards, and Y Toya, and C Schwencke, and D E Vatner, and S F Vatner, and Y Ishikawa
May 1984, International journal of cardiology,
N Oka, and K Asai, and R K Kudej, and J G Edwards, and Y Toya, and C Schwencke, and D E Vatner, and S F Vatner, and Y Ishikawa
March 1994, Circulation research,
N Oka, and K Asai, and R K Kudej, and J G Edwards, and Y Toya, and C Schwencke, and D E Vatner, and S F Vatner, and Y Ishikawa
January 1983, Journal of cardiovascular pharmacology,
N Oka, and K Asai, and R K Kudej, and J G Edwards, and Y Toya, and C Schwencke, and D E Vatner, and S F Vatner, and Y Ishikawa
February 2009, The Journal of thoracic and cardiovascular surgery,
N Oka, and K Asai, and R K Kudej, and J G Edwards, and Y Toya, and C Schwencke, and D E Vatner, and S F Vatner, and Y Ishikawa
March 2016, International journal of cardiology,
N Oka, and K Asai, and R K Kudej, and J G Edwards, and Y Toya, and C Schwencke, and D E Vatner, and S F Vatner, and Y Ishikawa
March 1995, Cardioscience,
N Oka, and K Asai, and R K Kudej, and J G Edwards, and Y Toya, and C Schwencke, and D E Vatner, and S F Vatner, and Y Ishikawa
January 1993, Convulsive therapy,
Copied contents to your clipboard!